Cargando…
Transdermal Vaccination with the Matrix-2 Protein Virus-like Particle (M2e VLP) Induces Immunity in Mice against Influenza A Virus
In this study, our goal was to utilize the extracellular domain matrix-2 protein virus-like particle (M2e VLP) that has been found to be highly conserved amongst all strains of influenza and could serve as a potential vaccine candidate against influenza. Previous studies have demonstrated that the V...
Autores principales: | Braz Gomes, Kimberly, D’Sa, Sucheta, Allotey-Babington, Grace Lovia, Kang, Sang-Moo, D’Souza, Martin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619166/ https://www.ncbi.nlm.nih.gov/pubmed/34835255 http://dx.doi.org/10.3390/vaccines9111324 |
Ejemplares similares
-
Transdermal Immunization with Microparticulate RSV-F Virus-like Particles Elicits Robust Immunity
por: D’Sa, Sucheta, et al.
Publicado: (2022) -
Enhanced Immunogenicity of an Influenza Ectodomain Matrix-2 Protein Virus-like Particle (M2e VLP) Using Polymeric Microparticles for Vaccine Delivery
por: Gomes, Keegan Braz, et al.
Publicado: (2022) -
Vaccine-Induced Immunity Elicited by Microneedle Delivery of Influenza Ectodomain Matrix Protein 2 Virus-like Particle (M2e VLP)-Loaded PLGA Nanoparticles
por: Braz Gomes, Keegan, et al.
Publicado: (2023) -
Complementary and Alternative Medicine Use for Primary Dysmenorrhea among Senior High School Students in the Western Region of Ghana
por: Samba Conney, Catherine, et al.
Publicado: (2019) -
Quinine Sulphate Microparticles as Treatment for Leishmaniasis
por: Allotey-Babington, Grace Lovia, et al.
Publicado: (2020)